Skip to content
跳至主要內容
SPY
···
QQQ
···
IWM
···
DIA
···
AAPL
···
MSFT
···
NVDA
···
GOOGL
···
AMZN
···
META
···
TSLA
···
BRK.B
···
JPM
···
GLD
···
TLT
···
BTC
···
ETH
···
VIXY
···
UUP
···
USO
···
SPY
···
QQQ
···
IWM
···
DIA
···
AAPL
···
MSFT
···
NVDA
···
GOOGL
···
AMZN
···
META
···
TSLA
···
BRK.B
···
JPM
···
GLD
···
TLT
···
BTC
···
ETH
···
VIXY
···
UUP
···
USO
···
Stock detail
Loading institutional stock data...
← BACK TO COCKPIT
ALL TICKERS →
OPTIONS CHAIN →
CAMP
CAMP4 THERAPEUTICS CORPORATION
NASDAQGM
Biotechnology
United States
$4.48
▼
-0.01 (-0.22%)
POST
—
OPEN
$4.45
HIGH
$4.64
LOW
$4.33
PREV CLOSE
$4.49
VOLUME
104.6K
0.38x avg
BID / ASK
2.94 / 5.46
spr 2.520
MARKET CAP
$281.1M
DAY RANGE
$4.33
$4.64
P/E (TTM)
—
Fwd -5.6
EPS (TTM)
-2.31
DIV YIELD
—
52W HIGH
$7.75
-42.2%
52W LOW
$1.46
+206.8%
BETA
—
vs S&P 500
DES
FA
GP
OPT
HLDR
EARN
CMP
COMPARE
ASK DESK
PRE-MARKET
$4.45
-0.04
(-0.89%)
LAST SURPRISE
—
—
NEXT EARNINGS
—
—
CATALYST
No fresh catalyst
—
ANALYST
—
—
SHORT INT
—
—
OPTIONS IV
—
—
CAMP
$4.48
▼
-0.22%
Chart
Valuation
Financials
Peers
News
CAMP · K 線技術分析（即時、可互動）
basic
pro
快速分析（約 90–120 秒）
Loading K-line chart…
按上方「快速分析」，研究台會以這張 K 線為起點跑一輪快速回答：三個分析師視角（總經、基本面、技術面）加交易計畫與風險統計，約 90–120 秒。想要五隊深度研究與機構級報告，請在研究台把模式切到「深度」。
1-YEAR PRICE
One-Year Trajectory
RISK-ON
253 BARS · +202.7% YOY
1-year price chart. Started at 1.48, currently 4.48, up 202.7 percent. Range 1.48 to 7.13 over 253 data points.
2025-09-04
$1.48 → $4.48 (+202.7%)
2026-09-04
§ Valuation
Loading § Valuation
§ Multi-Year Financials
Loading § Multi-Year Financials
§ Peers
Loading § Peers
§ Recent News
Loading § Recent News
EDITORIAL · NOT INVESTMENT ADVICE.
Data sources: Finnhub (quote / profile / news / peers) + Yahoo (stats) + SEC EDGAR XBRL (financials + DCF). All values cached for 5 minutes via ISR.
VALUATION
Deterministic Valuation (SEC EDGAR + Finnhub)
—
NO DCF
DCF Fair Value
—
DCF vs Spot
—
Comps Fair Value
—
WACC Used
+7.0%
Terminal g
+3.5%
Peers:
FATE
FHTX
NWBO
MGNX
ALEC
ANIK
ALXO
RNAC
⚠ DCF skipped: missing FCF or shares data from SEC EDGAR. Often the case for non-US issuers.
FINANCIALS
Multi-Year Financials (SEC XBRL)
RISK-ON
YOY REV +436.5% · 3 FY
FY
Revenue
Net Income
OCF
FCF
Assets
2025-12
$3.5M
-$80.4M
-$29.6M
-$29.8M
$117.8M
2024-12
$652.0K
-$51.8M
-$45.6M
-$46.0M
$78.3M
2023-12
$350.0K
-$49.3M
-$44.2M
-$44.8M
$54.9M
PEERS
Sector & Industry Peers
CALM
10 PEERS · FINNHUB
FATE
FHTX
NWBO
MGNX
ALEC
ANIK
ALXO
RNAC
TRDA
CYDY
NEWS
Recent News (past 14 days)
CALM
10 HEADLINES · LAST 14 DAYS
CAMP4 to Participate in Upcoming Investor Conferences
GlobeNewswire · 2026-09-01
Camp4 Therapeutics Insider Sold Shares Worth $879,719, According to a Recent SEC Filing
MT Newswires · 2026-08-21
CAMP4 Therapeutics Corporation (CAMP) Reports Q2 Loss, Tops Revenue Estimates
Zacks · 2026-08-13
CAMP4 Reports Second Quarter 2026 Financial Results and Corporate Highlights
GlobeNewswire · 2026-08-13
Ocugen (OCGN) Reports Q2 Loss, Beats Revenue Estimates
Zacks · 2026-08-06
MannKind (MNKD) Reports Q2 Loss, Beats Revenue Estimates
Zacks · 2026-08-05
CAMP4 Therapeutics Announces Second Closing of $100 Million Private Placement
GlobeNewswire · 2026-08-04
CRISPR Therapeutics AG (CRSP) Reports Q2 Loss, Tops Revenue Estimates
Zacks · 2026-08-03